Companies: 10,795·Total market cap: $144.5T

Heat Biologics, Inc.

Heat Biologics, Inc.

HTBXAMEXHealthcare

$2.38

+$0.01(+0.42%)

Market Cap$61074370

P/E Ratio—

52W High$2.48

52W Low$2.33

Avg Volume155K

Open$2.41

Beta0.30

Net Income Financials Revenue

Heat Biologics, Inc. (HTBX) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

HTBX · net income · updated Jun 9, 2026

Core profitability metrics

HTBX · net income · margin · TTM · CAGR

Net income was −$35.4M for FY2021 (fiscal year ending 2021-12-31), down 35.9% year-over-year. Net profit margin was -1675.5%.

FY2021 Net Income−$35.4M▼ -35.9% YoY

Trailing 12M (TTM)−$32.81Ttrailing 4 quarters sum

Net Profit Margin< −999%−$35.4M ÷ $2.1M

YoY Change-35.9%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · HTBX net income history · HTBX profit margin

Annual net income data

HTBX · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2021Loss−$35.4M▼ 35.9%-1675.5%$2.1M

FY2020Loss−$26.0M▼ 30.1%-883.6%$2.9M

FY2019Loss−$20.0M▼ 27.2%-656.5%$3.0M

FY2018Loss−$15.7M▼ 32.9%-271.6%$5.8M

FY2017Loss−$11.8M▲ +5.8%-779.1%$1.5M

Net income vs peers (Healthcare)

HTBX vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

#1

Heat Biologics, Inc.YOU

HTBX

−$35.4M-35.9%-1675.5%

Loss

Johnson & Johnson

$26.80B+90.6%28.5%

Eli Lilly and Company

$20.64B+94.9%31.7%

UnitedHealth Group Incorporated

$12.06B-16.3%2.7%

$4.23B-1.2%6.9%

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Heat Biologics, Inc. (HTBX) reported net income of −$35.4M for FY2021 (fiscal year ending 2021-12-31), down 35.9% year-over-year. The net profit margin was -1675.5% — meaning the company kept $-16.76 of every dollar of revenue as profit.

Heat Biologics, Inc. has not yet achieved annual profitability based on available data (11 fiscal years). The company has reported net losses across all available periods.

Heat Biologics, Inc.'s net profit margin was -1675.5% for FY2021, based on the latest annual results.

Investors sometimes search for "Heat Biologics, Inc. net worth" — the company's market capitalization is a separate figure from HTBX net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

HTBX net income · 4 questions

Heat Biologics, Inc. is not currently profitable on an annual basis. The company reported a net loss of $35.4M for FY2021.

is HTBX profitabledoes HTBX make a profitHTBX profitabilityHTBX profitable company

▸ Source: FMP /income-statement · GAAP · Heat Biologics, Inc. · Heat Biologics, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026